Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Camlin Fine Sciences Limited ( (IN:CAMLINFINE) ) has issued an announcement.
Camlin Fine Sciences Limited has announced the completion of a significant acquisition involving the allotment of 41,06,181 equity shares to acquire ordinary shares of the French company Vinpai. This strategic move, valued at over ₹101 crore, is expected to strengthen Camlin’s market position by expanding its international footprint and enhancing its product offerings. The new shares will rank equally with existing shares, increasing the company’s paid-up equity share capital and potentially impacting stakeholder value positively.
More about Camlin Fine Sciences Limited
Camlin Fine Sciences Limited operates in the specialty chemicals industry, focusing on the production of high-quality antioxidants and aroma chemicals. The company primarily serves the food, pet food, and animal nutrition markets, providing solutions that enhance shelf life and improve the quality of products.
Average Trading Volume: 32,193
Technical Sentiment Signal: Buy
Current Market Cap: 31B INR
Find detailed analytics on CAMLINFINE stock on TipRanks’ Stock Analysis page.

